ReviewInternational journal of molecular sciences2026

Somatostatin and Its Analogues as Second-Line Treatments in Non-Neoplastic Conditions.

Argyrios Periferakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.